IV iron before stomach cancer surgery
Treatments studied
Part of Blood & lymphatic, Cancer, Digestive system, Hormones & metabolism clinical trials.
This trial tests whether giving iron through a vein before surgery helps people with stomach (gastric) cancer who need an operation. It may be aimed at improving iron levels around the time of gastrectomy (stomach removal).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (18 or older) with stomach cancer planned for gastrectomy
- You can understand the study and provide consent (full understanding)
- Your pre-surgery blood counts/iron tests are not too high (not above set hemoglobin limits and transferrin saturation ≤ 50%)
- Your surgery is planned (not an emergency) and for cure, not for symptom relief (not palliative)
- You should not have certain iron-related problems (like iron overload, hemochromatosis, or polycythemia vera) or need dialysis for kidney failure
- You are not pregnant and you are not needing immediate blood transfusion due to very low hemoglobin or serious symptoms/heart disease
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving iron through a vein after heart surgery helps treat postoperative anemia (low red blood cells) in people age 70 and older. It may improve recovery by correcting low iron levels after surgery.
This trial tests whether giving iron (iron sucrose) can reduce anemia during chemotherapy before curative surgery. It may help you feel better and have smoother treatment by improving low blood counts caused by iron deficiency.
This Phase 3 study tests whether giving iron (as ferric carboxymaltose) after complex major surgery can improve recovery by helping your body rebuild blood and oxygen levels after blood loss. It may help patients who are having certain types of aortic, liver, or pancreas operations.
This Phase 3 study tests whether giving a specific iron medicine before major gynecologic cancer surgery can improve recovery. It’s mainly for people with low blood counts from low iron stores before surgery.
This Phase 3 study compares taking iron through an IV versus by mouth to treat iron-deficiency anemia after Roux-en-Y gastric bypass or sleeve gastrectomy. The goal is to see which method works better and is safer for improving iron levels and blood counts.
This trial tests a single dose of intravenous iron given after heart surgery to see if it helps prevent or reduce long-term anemia. It is for adults who already have low iron or anemia before surgery and who remain anemic the day after surgery.
Hear when a new Gastric Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.